Current Report Filing (8-k)
13 December 2022 - 12:31AM
Edgar (US Regulatory)
0001711291
false
0001711291
2022-12-07
2022-12-07
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
_______________________________________________________________________
FORM 8-K
__________________________________________________________________________
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event
reported): December 7, 2022
________________________________________________________________________
CURO GROUP HOLDINGS CORP.
(Exact Name of Registrant as Specified in Its
Charter)
________________________________________________________________________
| Delaware |
001-38315 |
90-0934597 |
| (State or other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| |
|
|
| 3615 North Ridge Road, Wichita, Kansas |
67205 |
| (Address of Principal Executive Offices) |
(Zip Code) |
(316) 772-3801
(Registrant’s Telephone Number, Including
Area Code)
N/A
(Former Name or Former Address, if Changed Since
Last Report)
________________________________________________________________________
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
Trading symbol(s) |
Name of each exchange on which registered |
| Common stock |
CURO |
NYSE |
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934(§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ☐
| ITEM 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers |
On November 15, 2022, CURO Group Holdings Corp. (the
“Company”) issued a press release announcing the resignation of Donald Gayhardt as Chief Executive Officer and as a director
of the Company. Effective December 7, 2022, the Company and Mr. Gayhardt entered into a Separation and Release Agreement, the terms of
which are consistent with the separation terms included in Mr. Gayhardt’s Employment and Non-Competition Agreement dated October
24, 2019. Mr. Gayhardt’s Employment Agreement was filed as Exhibit 10.46 to the Company’s Annual Report on 10-K, filed with
the Securities and Exchange Commission on March 7, 2022. Mr. Gayhardt’s Separation and Release Agreement is filed as Exhibit 10.2
to this Current Report on Form 8-K and incorporated herein by reference.
Douglas Clark, the Company’s
Chief Executive Officer and a director of the Company, entered into a pre-arranged stock trading plan providing for a third-party broker
to purchase shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), on his behalf and designed
to comply with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, and the Company’s insider trading policy regarding
transactions in the Company’s securities (the “10b5-1 Plan”).
The 10b5-1 Plan allows for
the purchase of up to 20,000 shares per month of Common Stock, up to a maximum of 250,000 shares, with a maximum purchase price of $6.00
per share. Purchases pursuant to the 10b5-1 Plan are expected to begin no earlier than January 5, 2023 after a 30-day waiting period and
will terminate no later than January 31, 2024, subject to the terms and conditions of the 10b5-1 Plan.
Transactions made
under the 10b5-1 Plan will be disclosed publicly through Form 4 filings with the Securities and Exchange Commission.
Except as may be required by law, the Company does not undertake to report on any specific Rule 10b5-1 pre-arranged stock trading plans
of any Company officer or director, nor to report any modifications or terminations of any such plan.
| ITEM 9.01 | Financial Statements and Exhibits |
(d) Exhibits
Signatures
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 12th
day of December, 2022.
| |
CURO Group Holdings Corp. |
| |
|
|
| |
|
|
| |
By: |
/s/Rebecca Fox |
| |
|
Rebecca Fox |
| |
|
Chief Legal officer |
CURO (NYSE:CURO)
Historical Stock Chart
From Jun 2024 to Jul 2024
CURO (NYSE:CURO)
Historical Stock Chart
From Jul 2023 to Jul 2024
